What clinical trials are available for recurrent Lymphoma

Clinical Trials for Recurrent Lymphoma

I'd be happy to help you understand the landscape of clinical trials for recurrent lymphoma. However, I need to be upfront: I don't have access to a current, searchable database of active clinical trials, and the specific trials available to you depend on your lymphoma subtype, prior treatments, and location.

How to Find Clinical Trials

Here are the authoritative resources where you can search for current trials:

Primary Search Resources:

1. ClinicalTrials.gov (National Cancer Institute)

   • Go to clinicaltrials.gov
   • Search by: lymphoma type, location, and treatment status
   • Filter by "Recruiting" or "Active, not recruiting"

2. NCI Cancer Information Service (CIS)

   • Call: 1-800-4-CANCER (1-[phone removed])
   • They can help match you with trials based on your specific situation

3. Your Oncology Team

   • Your care team often has access to trials not widely advertised
   • They know which trials match YOUR specific case

What Types of Trials Exist for Recurrent Lymphoma

According to NCCN Guidelines and current research, trials for recurrent/relapsed lymphoma typically focus on:

CAR T-Cell Therapy Trials Anti-CD19 CAR T-cell therapy has become a major focus for recurrent B-cell lymphomas. According to PubMed Central research, three FDA-approved anti-CD19 CAR T-cell products are now standard of care for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma after 2 or more prior treatment lines:

• Axicabtagene ciloleucel
• Tisagenlecleucel
• Lisocabtagene maraleucel

These have shown unprecedented response rates in high-risk patients.

Molecular Residual Disease (MRD) Monitoring Trials According to NCCN Guidelines (December 2024), newer trials are investigating ctDNA-guided treatment strategies. For example:

• ALPHA3 trial (NCT06500273) - studying MRD-positive LBCL patients post-remission
• SHORTEN-ctDNA trial (NCT06693830) - exploring ctDNA-guided chemotherapy de-escalation

These trials use blood tests to detect remaining cancer cells and guide treatment decisions.

Other Trial Categories:

• Novel targeted therapies based on your lymphoma's specific mutations
• Combination immunotherapy approaches
• Radiation therapy combined with systemic treatment

Questions to Ask Your Oncology Team

To find the right trial for YOUR situation, ask:

1. "Are there any clinical trials available for my specific lymphoma subtype and stage of disease?"

2. "Based on my prior treatments, which trials would I be eligible for?"

3. "Are there any CAR T-cell therapy trials or MRD-guided treatment trials I should consider?"

4. "What are the potential benefits and risks of participating in a trial versus standard treatment?"

5. "How would trial participation affect my treatment schedule and follow-up care?"

Important Context

The NCCN Guidelines emphasize that clinical trials can offer access to newer treatments before they become widely available. For recurrent lymphoma, trials may represent your best option for accessing cutting-edge therapies, particularly if standard treatments haven't worked.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.